Biodegradation of 7-ketocholestrol (7-KC) by Thermobifidafusca IP1

Paper Details

Research Paper 01/04/2016
Views (216) Download (4)

Biodegradation of 7-ketocholestrol (7-KC) by Thermobifidafusca IP1

Irum Perveen, Shama Sehar, Iffat Naz, Muhammad Asam Raza, Azim Jahangir Khan, Safia Ahmed
Int. J. Biosci.8( 4), 83-93, April 2016.
Certificate: IJB 2016 [Generate Certificate]


7-ketocholesterol (7KC), an oxidized derivative of cholesterol, has been implicated in a variety of chronic diseases including atherosclerosis, Alzheimer’s disease, Parkinson’s disease, cancer and age-related macular degeneration. It is formed by the autooxidation of cholesterol and especially cholesterol-fatty acid esters found in lipoprotein deposits, its elevated concentrations are associated with disruption of cellular homeostasis, decreased cell viability, and increased cell death.Enzymatic cleavage of 7-KC can serve as a key solution for the cure of a number of chronic diseases directly associated with its accumulation. A bacterial strain isolated from manure piles was characterized taxonomically and identified as Thermobifida fusca IP1 on the basis of amplification and sequencing of 16s rDNA. This isolate was tested for its ability to degrade 7-ketocholesterol in M9 liquid medium and showed to utilize 7-KC as the sole carbon and energy source. The degradation of 7-KC was hundred percent when tested in liquid culture. High Performance Liquid Chromatography (HPLC) analysis also showed complete removal of the compound from the sample after twelve days. This bacteriacan effectively be used to remove 7-KC and can lead to the development of a single potential therapeutic enzyme preparation to target a number of above mentioned chronic diseases related to 7-KC.


Amaral  J,  Lee  JW,  Chou  J,  Campos  MM, Rodrıguez IR. 2013. 7-Ketocholesterol induces inflammation and angiogenesis in vivo: a novel rat model. PLoS One 8(2), e56099.

Arima K, Nagasawa M, Bae M, Tamura G. 1969. Microbial transformation of sterols. Part I. Decomposition of cholesterol by microorganisms. Agricultural and Biological Chemistry 33, 1636–1643.

Berthier A, Lemaire-Ewing S, Prunet C, MonierS, Athias A, Bessede G, Pais de Barros JP, Laubriet A, Gambert P, Lizard G, Neel D. 2004.Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death and Differentiation 11(8), 897-905.

Bjo¨rkhem I, Cedazo-Minguez A, Leoni V, Meaney S. 2009. Oxysterols and neurodegenerative diseases. Molecular Aspects of Medicine 30, 171–179.

Bortolini O, Medici A, Poli S. 1997. Biotransform ations on steroid nucleus of bile acids. Steroids 62, 564–577.

Brown RL, Peterson GE. 1966. Cholesterol oxidation by soil Actinomycetes. Journal of General Microbiology 45, 441–450.

Brown AJ, Jessup W. 1999. Oxysterols and atherosclerosis. Atherosclerosis 142(1), 1–28. Review.

Brown AJ, Mander EL, Gelissen IC, Kritharides L, Dean RT, Jessup W. 2000. Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells. Accumulation of oxidized esters in lysosomes. The Journal of Lipid Research 41(2), 226–237.

Carter CJ. 2007. Convergence of genes implicated in Alzheimer’s disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis. Neurochemistry International 50, 12–38.

Casserly I, Topol E. 2004. Convergence of atherosclerosis and Alzheimer’s disease: inflammation, cholesterol, and misfolded proteins. Lancet 363, 1139–1146.

Cox BE, Griffin EE, Ullery JC, Jerome WG. 2007. Effects of cellular cholesterol loading on macrophage foam cell lysosome acidification. The Journal of Lipid Research 48(5), 1012–1021.

De Grey AD. Alvarez PJ, Brady RO, Cuervo AM, Jerome WG, McCarty PL, Nixon RA, Rittmann BE, Sparrow JR. 2005. Medical bioremediation: prospects for the application of microbial catabolic diversity to aging and several major age-related diseases. Ageing Research Reviews 4(3), 315-338.

Donova MV, Egorova OV. 2012. Microbial steroid transformations: current state and prospects. Applied Microbiology and Biotechnology 94, 1423–1447.

Dreizen S, Stern MH, Levy BM. 1978. Diet-induced arteriopathies in the rabbit aorta and oral vasculature. Journal of Dental Research 57, 412–417.

Drzyzga O, Navarro Llorens JM, Fernández de Las Heras L, GarcíaFernández E, Perera J. 2009. Gordoniacholesterolivorans sp. nov., a cholesterol-degrading actinomycete isolated from sewage sludge. International Journal of Systematic and Evolutionary Microbiology 59, 1011–1015.

Drzyzga O, Fernández de lasHeras L, Morales V, Navarro Llorens JM, Perera J. 2011. Cholesterol degradation by Gordonia cholesterolivorans. Applied and Environmental Microbiology 77, 4802–4810.

Dzeletovic S, Babiker A, Lund E, Diczfalusy U. 1995. Time course of oxysterol formation during in vitro oxidation of low density lipoprotein. Chemistry and Physics of Lipids 78, 119–128.

Fernández de Las Heras L, GarcíaFernández E, María Navarro Llorens J, Perera J, Drzyzga O. 2009. Morphological, physiological, and molecular characterization of a newly isolated steroid-degrading actinomycete, identified as Rhodococcusruber strain Chol-4. Current Microbiology 59, 548–553.

Ferreira NP, Tracey RP. 1984. Numerical taxonomy of cholesterol-degrading soil bacteria. Journal of Applied Microbiology 57, 429–446.

Fraldi A, Annunziata F, Lombardi A, Kaiser HJ, Medina DL, Spampanato C, Fedele AO, Polishchuk R, SorrentinoNC, Simons K, Ballabio A. 2010. Lysosomal fusion and SNARE function are impaired by cholesterol accumulation in lysosomal storage disorders. The EMBO Journal 29(21), 3607–3620.

Garcia-Cruset S, Carpenter KL, Guardiola F, Stein BK, Mitchinson MJ. 2001. Oxysterol profiles of normal human arteries, fatty streaks and advanced lesions. Free Radical Research 35, 31–41.

Ge F, Li W, Chen G, Liu Y, Zhang G, Yong B, Wang Q, Wang N, Huang Z, Li W, Wang J, Wu C, Xie Q, Liu G. 2011. Draft genome sequence of Gordonianeofelifaecis NRRL B-59395, a cholesterol-degrading actinomycete. Journal of Bacteriology 193, 5045–5046.

Holert J, Kulic Z, Yucel O, Suvekbala V, Suter MJ, Moller HM, Philipp B. 2013. Degradation of the acyl side chain of the steroid compound cholate in Pseudomonas sp. Strain Chol1 proceeds via an aldehyde intermediate. Journal of Bacteriology 195, 585–595.

Kaushik S, Massey AC, Cuervo AM. 2006. Lysosome membrane lipid microdomains: Novel regulators of chaperone-mediated autophagy. The EMBO Journal 25(17), 3921–3933.

Kostka JE, Prakash O, Overholt WA, Green SJ, Freyer G, Canion A, Delgardio J, Norton N, Hazen TC, Huettel M. 2011. Hydrocarbon-degrading bacteria and the bacterial community response in Gulf of Mexico beach sands impacted by the deepwater horizon oil spill. Applied and Environmental Microbiology 77(22), 7962–7974.

Leonarduzzi G, Sottero B, Poli G. 2002. Oxidized products of cholesterol: dietary and metabolic origin, and proatherosclerotic effects (review). The Journal of nutritional biochemistry 13(12), 700-710.

Lizard G, Monier S, Cordelet C, Gesquiere L, Deckert V, Gueldry S, Lagrost L, Gambert P. 1999. Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7beta-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall. Arteriosclerosis Thrombosis, and Vascular Biology 19, 1190– 1200.

Lordan  S,  Mackrill  JJ,  O’Brien  NM.  2009. Oxysterols and mechanisms ofapoptoticsignaling: implications in the pathology of degenerative diseases. The Journal of Nutritional Biochemistry 20, 321–336.

Mahato SB, Garai S. 1997. Advances in microbial steroid biotransformation. Steroids 62, 332–345.

Maor I, Mandel H, Aviram M. 1995. Macrophage uptake of oxidized LDL inhibits lysosomalsphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. A possible role for 7-Ketocholesterol. Arteriosclerosis Thrombosis, and Vascular Biology 15(9), 1378–1387.

Mathieu JM, Schloendorn J, Rittmann BE, Alvarez PJ. 2009. Medical bioremediation of age-related diseases. Microbial Cell Factories 8, 21.

Mathieu JM, Wang F, Segatori L, Alvarez PJ. 2012. Increased resistance to oxysterol cytotoxicity in fibroblasts transfected with a lysosomally targeted Chromobacterium oxidase. Biotechnology and Bioengineering 109, 2409–2415.

Merino E, Barrientos A, Rodríguez J, Naharro G, Luengo JM, Olivera ER. 2013. Isolation of cholesterol- and deoxycholate-degrading bacteria from soil samples: evidence of a common catabolic steroid-degrading pathway involved in steroid assimilation. Applied Microbiology and Biotechnology 97, 891–904.

Moreira EF, Larrayoz IM, Lee JW, Rodrı´guez IR. 2009. 7-Ketocholesterol is present in lipid deposits in the primate retina: potential implication in the induction of VEGF and CNV formation. Investigative Ophthalmology and Visual Science 50, 523–532.

induce apoptosis of human vascular smooth muscle cells. Journal of  Atherosclerosis and Thrombosis 13, 256–262.

Poli G, Biasi F, Leonarduzzi G. 2013. Oxysterols in the pathogenesis of major chronic diseases. Redox Biology 31, 125–130. Review.

Rimner A, Al Makdessi S, Sweidan H, Wischhusen J, Rabenstein B, Shatat K, Mayer P, Spyridopoulos I. 2005. Relevance and mechanism of oxysterolstereospecifity in coronary artery disease. Free Radical Biology and Medicine 38(4), 535-544.

Rittmann BE, Schloendorn J. 2007. Engineering away lysosomal junk: medical bioremediation. Rejuvenation Research 10, 359–365.

Rodriguez IR, Alam S, Lee JW. 2004. Cytotoxicity of oxidized low-density lipoprotein in cultured RPE cells is dependent on the formation of 7-ketocholesterol. Investigative Ophthalmology and Visual Science 45, 2830–2837.

Rodrı´guez IR, Larrayoz IM. 2010. Cholesterol oxidation in the retina: implications of 7KCh formation in chronic inflammation and age-related macular degeneration. The Journal of Lipid Research 51, 2847–2862. Review.

Spyridopoulos I, Wischhusen J, Rabenstein B, Mayer P, Axel DI, Frohlich KU, KarschKR. 2001. Alcohol enhances oxysterol-induced apoptosis in human endothelial cells by a calcium-dependent mechanism. Arteriosclerosis, Thrombosis, and Vascular Biology 21(3), 439-444.

vanReyk DM, Brown AJ, Hult’en LM, Dean RT, Jessup W. 2006. Oxysterols in biological systems: sources, metabolism and pathophysiological relevance. Redox Report 11, 255–262. Review.

Vaya J, Schipper HM. 2007. Oxysterols, cholesterol homeostasis, and Alzheimer disease. Journal of Neurochemistry 102, 1727–1737.

Vejux A, Malvitte L, Lizard G. 2008. Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis. Brazilian Journal of Medical and Biological Research 41, 545–556. 01

Vejux A, Lizard G. 2009. Cytotoxic effects of oxysterols associated with human diseases: Induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Molecular Aspects of Medicine 30, 153–170. Review.

Wang SF, Chou YC, Mazumder N, Kao FJ, Nagy LD, Guengerich FP, Huang C, Lee HC, Lai PS, Ueng YF. 2013. 7-Ketocholesterol induces P-glycoprotein through PI3K/mTORsignaling in hepatoma cells. Biochemical Pharmacology 86, 548–560.

Whitmarsh JM. 1964. Intermediates of microbiological metabolism of cholesterol. Biochemical Journal 90, 23-24.